Kanski, J. ., Aksenova, M. ., Schöneich, C. ., & Butterfield, D. . (2002). Substitution of isoleucine-31 by helical-breaking proline abolishes oxidative stress and neurotoxic properties of Alzheimer’s amyloid beta-peptide. Free Radical Biology & Medicine, 32(11), 1205-11. https://doi.org/10.1016/s0891-5849(02)00821-3 (Original work published 2002)

Drake, J. ., Kanski, J. ., Varadarajan, S. ., Tsoras, M. ., & Butterfield, D. . (2002). Elevation of brain glutathione by gamma-glutamylcysteine ethyl ester protects against peroxynitrite-induced oxidative stress. Journal of Neuroscience Research, 68(6), 776-84. https://doi.org/10.1002/jnr.10266 (Original work published 2002)

Butterfield, D. ., & Kanski, J. . (2002). Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer’s amyloid beta-peptide 1-42. Peptides, 23(7), 1299-309. https://doi.org/10.1016/s0196-9781(02)00066-9

Castegna, A. ., Aksenov, M. ., Aksenova, M. ., , Klein, J. ., Pierce, W. ., … Butterfield, D. . (2002). Proteomic identification of oxidatively modified proteins in Alzheimer’s disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radical Biology & Medicine, 33(4), 562-71. https://doi.org/10.1016/s0891-5849(02)00914-0 (Original work published 2002)

Butterfield, D. ., Castegna, A. ., Drake, J. ., Scapagnini, G. ., & . (2002). Vitamin E and neurodegenerative disorders associated with oxidative stress. Nutritional Neuroscience, 5(4), 229-39. https://doi.org/10.1080/10284150290028954

Yatin, S. ., Varadarajan, S. ., & Butterfield, D. . (2000). Vitamin E Prevents Alzheimer’s Amyloid beta-Peptide (1-42)-Induced Neuronal Protein Oxidation and Reactive Oxygen Species Production. Journal of Alzheimer’s Disease : JAD, 2(2), 123-131. https://doi.org/10.3233/jad-2000-2212

Ding, Q. ., Reinacker, K. ., Dimayuga, E. ., , Drake, J. ., Butterfield, D. ., … Keller, J. . (2003). Role of the proteasome in protein oxidation and neural viability following low-level oxidative stress. FEBS Letters, 546(2-3), 228-32. https://doi.org/10.1016/s0014-5793(03)00582-9 (Original work published 2003)

Castegna, A. ., , Klein, J. ., Lynn, B. ., Markesbery, W. ., & Butterfield, D. . (2003). Proteomic identification of nitrated proteins in Alzheimer’s disease brain. Journal of Neurochemistry, 85(6), 1394-401. https://doi.org/10.1046/j.1471-4159.2003.01786.x

Butterfield, D. ., & Pocernich, C. . The glutamatergic system and Alzheimer’s disease: therapeutic implications. CNS Drugs, 17(9), 641-52. https://doi.org/10.2165/00023210-200317090-00004 (Original work published 2003)

Kanski, J. ., Aksenova, M. ., & Butterfield, D. . (2002). The hydrophobic environment of Met35 of Alzheimer’s Abeta(1-42) is important for the neurotoxic and oxidative properties of the peptide. Neurotoxicity Research, 4(3), 219-23. https://doi.org/10.1080/10298420290023945